Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 11—November 2022
Research

Invasive Infections Caused by Lancefield Groups C/G and A Streptococcus, Western Australia, Australia, 2000–2018

Cameron M. WrightComments to Author , Rachael Moorin, Glenn Pearson, John Dyer, Jonathan Carapetis, and Laurens Manning
Author affiliations: Curtin University, Perth, Western Australia, Australia (C.M. Wright, R. Moorin); University of Tasmania, Hobart, Tasmania, Australia (C.M. Wright); The University of Western Australia, Crawley, Western Australia, Australia (C.M. Wright, R. Moorin, J. Carapetis, L. Manning); Fiona Stanley Fremantle Hospitals Group, Murdoch, Western Australia, Australia (C.M. Wright, J. Dyer, L. Manning); Telethon Kids Institute, University of Western Australia, Perth (G. Pearson, J. Carapetis, L. Manning); Perth Children’s Hospital, Perth (J. Carapetis)

Main Article

Table

Descriptive statistics of invasive group C/G Streptococcus disease, Western Australia, Australia, 2000–2018*

Characteristic No. (%)
Total
 1,270
Sex
F 400 (31)
M 866 (68)
Missing/unknown
 <5
Age group, y
<1 5 (0)
1–4 <5
5–14 6 (0)
15–24 52 (4)
25–34 80 (6)
35–44 133 (10)
45–54 181 (14)
55–64 222 (17)
65–74 244 (19)
75–84 215 (17)
>85 126 (10)
Missing/unknown
 <5
Indigenous status
Non-Indigenous 1,067 (84)
Indigenous 148 (12)
Missing/unknown
 55 (4)
Region of occurrence
Nontropical 1,175 (93)
Tropical 91 (7)
Missing/unknown
 <5
Remoteness
Major cities 855 (67)
Inner regional 92 (7)
Outer regional 128 (10)
Remote 81 (6)
Very remote 59 (5)
Missing/unknown
 55 (4)
Socioeconomic status
Most disadvantaged 384 (30)
More disadvantaged 280 (22)
Moderately disadvantaged 220 (17)
Less disadvantaged 184 (14)
Least disadvantaged 198 (16)
Missing/unknown
 <5
30-d all-cause deaths
 85 (7)
90-d all-cause deaths 114 (9)

*Categories with <5 patients are shown without accompanying percentage values to comply with confidentiality data requirements. Some rows do not sum to 100 because of this or because of rounding. Analogous data for invasive group A Streptococcus disease has been published separately (15).

Main Article

References
  1. Hughes  GJ, VAN Hoek  AJ, Sriskandan  S, Lamagni  TL. The cost of hospital care for management of invasive group A streptococcal infections in England. Epidemiol Infect. 2015;143:1719–30. DOIPubMedGoogle Scholar
  2. Parks  T, Barrett  L, Jones  N. Invasive streptococcal disease: a review for clinicians. Br Med Bull. 2015;115:77–89. DOIPubMedGoogle Scholar
  3. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(RR-10):1–55.PubMedGoogle Scholar
  4. Facklam  R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002;15:613–30. DOIPubMedGoogle Scholar
  5. Sikder  S, Williams  NL, Sorenson  AE, Alim  MA, Vidgen  ME, Moreland  NJ, et al. Group G Streptococcus induces an autoimmune carditis mediated by interleukin 17A and interferon γ in the Lewis rat model of rheumatic heart disease. J Infect Dis. 2018;218:324–35. DOIPubMedGoogle Scholar
  6. Haidan  A, Talay  SR, Rohde  M, Sriprakash  KS, Currie  BJ, Chhatwal  GS. Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet. 2000;356:1167–9. DOIPubMedGoogle Scholar
  7. Brandt  ER, Sriprakash  KS, Hobb  RI, Hayman  WA, Zeng  W, Batzloff  MR, et al. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat Med. 2000;6:455–9. DOIPubMedGoogle Scholar
  8. Public Health England. Notifiable diseases: annual report. Manchester: Public Health England; 2020 [cited 2020 Oct 6]. https://www.gov.uk/government/publications/notifiable-diseases-annual-report
  9. Government of Canada. National case definition: Invasive group A streptococcal disease. Ottawa: Government of Canada; 2019 [cited 2019 Mar 30]. https://www.canada.ca/en/public-health/services/diseases/group-a-streptococcal-diseases/health-professionals/national-case-definition.html
  10. Fujiya  Y, Hayakawa  K, Gu  Y, Yamamoto  K, Mawatari  M, Kutsuna  S, et al. Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections. PLoS One. 2019;14:e0211786. DOIPubMedGoogle Scholar
  11. Babiker  A, Li  X, Lai  YL, Strich  JR, Warner  S, Sarzynski  S, et al. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis. 2021;21:697–710. DOIPubMedGoogle Scholar
  12. Gajdács  M, Ábrók  M, Lázár  A, Burián  K. Beta-haemolytic group A, C and G streptococcal infections in southern Hungary: a 10-year population-based retrospective survey (2008–2017) and a review of the literature. Infect Drug Resist. 2020;13:4739–49. DOIPubMedGoogle Scholar
  13. Kittang  BR, Bruun  T, Langeland  N, Mylvaganam  H, Glambek  M, Skrede  S. Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes. Clin Microbiol Infect. 2011;17:358–64. DOIPubMedGoogle Scholar
  14. Oppegaard  O, Mylvaganam  H, Kittang  BR. Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey. Clin Microbiol Infect. 2015;21:171–8. DOIPubMedGoogle Scholar
  15. Wright  CM, Moorin  R, Pearson  G, Dyer  JR, Carapetis  JR, Manning  L. Increasing incidence of invasive group A streptococcal disease in Western Australia, particularly among Indigenous people. Med J Aust. 2021;215:36–41. DOIPubMedGoogle Scholar
  16. Benchimol  EI, Smeeth  L, Guttmann  A, Harron  K, Moher  D, Petersen  I, et al.; RECORD Working Committee. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12:e1001885. DOIPubMedGoogle Scholar
  17. Australian Bureau of Statistics. Table 4. Estimated resident population, states and territories (Number). 2020 [cited 2020 Jan 8]. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Mar%202018?OpenDocument
  18. Australian Bureau of Statistics. Estimates and Projections, Aboriginal and Torres Strait Islander Australians [cited 2020 Jun 2]. https://www.abs.gov.au/AUSSTATS/abs@.nsf/mf/3238.0
  19. Government of Western Australia. Regional Population Data [cited 2020 Sep 17]. https://catalogue.data.wa.gov.au/dataset/western-australia-regional-population/resource/eeecaf08-55e3-4026-99fc-f98a383e2812
  20. Cannon  J, Dyer  J, Carapetis  J, Manning  L. Epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. Clin Microbiol Infect. 2018;24:1084–8. DOIPubMedGoogle Scholar
  21. Cannon  J, Rajakaruna  G, Dyer  J, Carapetis  J, Manning  L. Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study. Clin Microbiol Infect. 2018;24:1089–94. DOIPubMedGoogle Scholar
  22. Kelman  CW, Bass  AJ, Holman  CD. Research use of linked health data—a best practice protocol. Aust N Z J Public Health. 2002;26:251–5. DOIPubMedGoogle Scholar
  23. Boyd  R, Patel  M, Currie  BJ, Holt  DC, Harris  T, Krause  V. High burden of invasive group A streptococcal disease in the Northern Territory of Australia. Epidemiol Infect. 2016;144:1018–27. DOIPubMedGoogle Scholar
  24. Australian Bureau of Statistics. The Australian Statistical Geography Standard (ASGS) remoteness structure [cited 2018 Oct 5]. https://www.abs.gov.au/websitedbs/d3310114.nsf/home/remoteness+structure
  25. Australian Bureau of Statistics. Socioeconomic indices for areas [cited 2018 Oct 15]. https://www.abs.gov.au/websitedbs/censushome.nsf/home/seifa
  26. Broyles  LN, Van Beneden  C, Beall  B, Facklam  R, Shewmaker  PL, Malpiedi  P, et al. Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis. 2009;48:706–12. DOIPubMedGoogle Scholar
  27. Harris  P, Siew  DA, Proud  M, Buettner  P, Norton  R. Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period. Clin Microbiol Infect. 2011;17:1216–22. DOIPubMedGoogle Scholar
  28. Thomsen  RW, Riis  AH, Kjeldsen  S, Schønheyder  HC. Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G. J Infect. 2011;63:8–16. DOIPubMedGoogle Scholar
  29. Moon  A, Gray  A, Deehan  D. Neck of femur fractures in patient’s aged more than 85 years—are they a unique subset? Geriatr Orthop Surg Rehabil. 2011;2:123–7. DOIPubMedGoogle Scholar
  30. Shahin  A, Saba  M, Greene  J. A retrospective chart review on the clinical characteristics and outcomes of cancer patients with group C, F, or G β-hemolytic streptococcal infections. Infect Dis Clin Pract. 2019;27:205–10. DOIGoogle Scholar
  31. Lewthwaite  P, Parsons  HK, Bates  CJ, McKendrick  MW, Dockrell  DH. Group G streptococcal bacteraemia: an opportunistic infection associated with immune senescence. Scand J Infect Dis. 2002;34:83–7. DOIPubMedGoogle Scholar

Main Article

Page created: September 06, 2022
Page updated: October 21, 2022
Page reviewed: October 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external